Integra LifeSciences Holdings Corporation Stock

Equities

IART

US4579852082

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 12:58:10 2024-04-26 pm EDT 5-day change 1st Jan Change
28.2 USD -0.74% Intraday chart for Integra LifeSciences Holdings Corporation -1.19% -34.93%
Sales 2024 * 1.62B Sales 2025 * 1.71B Capitalization 2.23B
Net income 2024 * 117M Net income 2025 * 174M EV / Sales 2024 * 2.17 x
Net Debt 2024 * 1.27B Net Debt 2025 * 1.37B EV / Sales 2025 * 2.11 x
P/E ratio 2024 *
20.3 x
P/E ratio 2025 *
13.5 x
Employees 3,946
Yield 2024 *
-
Yield 2025 *
-
Free-Float 74.16%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Integra LifeSciences Holdings Corporation

1 day-3.30%
1 week-10.18%
Current month-19.86%
1 month-14.94%
3 months-32.02%
6 months-19.62%
Current year-34.76%
More quotes
1 week
27.18
Extreme 27.18
29.80
1 month
27.18
Extreme 27.18
35.49
Current year
27.18
Extreme 27.18
45.42
1 year
27.18
Extreme 27.18
56.21
3 years
27.18
Extreme 27.18
77.40
5 years
27.18
Extreme 27.18
77.40
10 years
21.78
Extreme 21.7769
77.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 21-11-30
Director of Finance/CFO 52 23-06-27
Chairman 62 97-11-30
Members of the board TitleAgeSince
Director/Board Member 62 Dec. 11
Chairman 62 97-11-30
Director/Board Member 63 05-12-31
More insiders
Date Price Change Volume
24-04-26 28.33 -0.28% 157 953
24-04-25 28.41 -3.30% 1,581,147
24-04-24 29.38 0.00% 900,280
24-04-23 29.38 +1.38% 1,006,634
24-04-22 28.98 +1.05% 1,611,698

Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT

More quotes
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
28.41 USD
Average target price
44.8 USD
Spread / Average Target
+57.69%
Consensus